Location: BlackRock Offices, 55 East 52nd Street, New York, NY, USA 10055

Date: 20/03/2017

New York- Superbugs & Super Risks: The Investment Case for Action

The FAIRR Initiative is pleased to invite you to join us for an event on antibiotic resistance and investment risk in New York City on Monday March 20th 2017, kindly hosted by BlackRock.

Increasing rates of antibiotic resistance pose a major threat to human health worldwide. The implications for the investment sector are also substantial. Left unchecked, by 2050 drug-resistant infections could be claiming 10 million lives annually and wiping $100 trillion from global GDP.

The event will be a forum for investors to learn more about the material risks associated with this issue, to explore strategies to identify and manage these risks, and to share investor and company perspectives on opportunities and challenges in addressing resistance.


Event agenda:

15:30 Registration

16:00Welcome address: Michelle Edkins, Managing Director, BlackRock
Introduction: Maria Lettini, Director, FAIRR

16:10Keynote: Dr Lance Price, Director, Antibiotic Resistance Action Center, Milken Institute School of Global Health, George Washington University

16:30 – Policy and market trends update: Erik Olson, Director, Health & Environment Program; Senior Strategic Director Food & Health, Natural Resources Defense Council
16:40 – Panel session:
Integrating antibiotic risks into investment processes and corporate practices
Moderator: Bruce Kahn, Portfolio Manager, Sustainable Insight Capital Management
Panellists: Abigail Herron, Head of Responsible Investment Engagement, Aviva Investors
Leslie Samuelrich, President, Green Century Capital Management
Dr Bruce Stewart-Brown, DVM, Sr VP of Food Safety, Quality, and Live Production, Perdue Foods
Joshua Brau, Director of Food With Integrity Program, Chipotle
18:00 Networking reception


Please RSVP to events@fairr.org